yangjianjun

1 clinical trials · Sponsor

Record	Firm	Date
Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer (NCT06550453)	yangjianjun	2024-09-01

Every clearance here is in the API, with alerts when new ones post.